drugset / Trial / NCT06202612
A SHR0302 BA Study on Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate and compare the pharmacokinetics of SHR0302 two different kind tablets in Healthy subjects after administration two kind tablets (quick release tablets and sustained-release tablets).
Timeline
- Start
- 2024-01-16
- Primary completion
- 2024-02-21
- Completion
- 2024-02-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SHR0302 | Unknown | 8 mg | — |
| Subject | SHR0302 | Unknown | 10 mg | — |